Physician profile
Marc Schumer
NPI 1407819691
$10,506.63
in general payments reported to CMS, 2019-2025
21 companies · $8,279 in 2025
The $8,279 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $776 · 2020: $284 · 2021: $978 · 2023: $95.77 · 2024: $94.00 · 2025: $8,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,300 · Travel and Lodging: $2,184 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $891 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,300.00 |
| Travel and Lodging | $2,183.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $891.11 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $4,150.93 | 2019-2025 | Erleada, Akeega |
| Avyxa Pharma, LLC | $4,117.82 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $930.00 | 2021 | |
| Astellas Pharma US INC | $342.53 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $214.87 | 2019 | |
| Immunitybio, INC. | $162.08 | 2025 | |
| Medtronic USA, INC. | $144.21 | 2020 | |
| Teleflex LLC | $82.36 | 2023 | Urolift |
| Dendreon Pharmaceuticals LLC | $65.86 | 2019-2020 | |
| Pfizer INC. | $63.54 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.69 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $41.47 | 2019 | |
| Coloplast Corp | $23.26 | 2019 | |
| Travere Therapeutics, INC. | $22.22 | 2019 | |
| 180 Medical, INC. | $18.79 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $15.12 | 2021 | |
| Allergan, INC. | $14.32 | 2019 | |
| Rochester Medical Corporation | $13.93 | 2020 | |
| Olympus America INC. | $13.41 | 2023 | Visera 4k Uhd Camera Control Unit |
| Hollister Incorporated | $11.62 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Schumer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.